Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Tandem Diabetes Care, Inc. - Common Stock
(NQ:
TNDM
)
16.78
-0.30 (-1.76%)
Streaming Delayed Price
Updated: 1:00 PM EDT, Jul 3, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Tandem Diabetes Care, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
Parexel Announces CEO Succession Plan
March 18, 2024
Chief Operating & Growth Officer Peyton Howell to succeed Jamie Macdonald effective May 15, 2024; Mr. Macdonald to retire as CEO and continue on the Board of Directors through Dec. 31, 2024
From
Parexel International LLC
Via
GlobeNewswire
Tandem Diabetes Care Stock Belongs On Your Watchlist As RS Rating Jump Higher
March 11, 2024
On Monday, Tandem Diabetes Care stock received an upgrade to its Relative Strength (RS) Rating, from 68 to 78.
Via
Investor's Business Daily
Tandem Diabetes Care Prices Upsized Private Placement of $275.0 Million of Convertible Senior Notes Due 2029
March 06, 2024
From
Tandem Diabetes Care, Inc.
Via
Business Wire
Why Tandem Diabetes Care Stock Popped Today
February 22, 2024
Tandem Diabetes climbed as investors focused on its strong outlook for the coming year.
Via
The Motley Fool
Tandem Diabetes Care: Q4 Earnings Insights
February 21, 2024
Via
Benzinga
Earnings Scheduled For February 21, 2024
February 21, 2024
Companies Reporting Before The Bell • Gatos Silver (NYSE:GATO) is estimated to report quarterly earnings at $0.09 per share on revenue of $83.00 million.
Via
Benzinga
2 Beaten-Down Stocks That Are Worth Buying
February 04, 2024
Don't be too quick to ignore these stocks.
Via
The Motley Fool
Why SOPHiA GENETICS Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
March 05, 2024
Shares of SOPHiA GENETICS SA (NASDAQ: SOPH) fell sharply during Tuesday’s session after the company reported worse than expected fourth-quarter earnings and issued 2024 guidance.
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
March 04, 2024
Via
Benzinga
Tandem Diabetes Care Announces Proposed Private Placement of Convertible Notes
March 04, 2024
From
Tandem Diabetes Care, Inc.
Via
Business Wire
DexCom: A Winner In Diabetes Management
February 25, 2024
Diabetes management and glucose monitoring solutions provider DexCom, Inc. recently released its fourth-quarter results, reporting $1.0 billion in revenue, up 27% year-over-year compared to $820...
Via
Talk Markets
Carvana Posts Q4 Results, Joins LegalZoom.com, Comfort Systems And Other Big Stocks Moving Higher On Friday
February 23, 2024
U.S. stocks were mostly higher, with the Dow Jones index gaining more than 100 points on Friday.
Via
Benzinga
Topics
Stocks
Tandem Diabetes Care Inc. (NASDAQ: TNDM) Making Surprising Moves in Thursday Session
February 22, 2024
Via
Investor Brand Network
Why MercadoLibre Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
February 23, 2024
Shares of MercadoLibre, Inc. (NASDAQ: MELI) fell sharply during Friday’s session after the company reported fourth-quarter financial results.
Via
Benzinga
Tandem Diabetes Care Announces Fourth Quarter and Full Year 2023 Financial Results and 2024 Financial Guidance
February 21, 2024
From
Tandem Diabetes Care, Inc.
Via
Business Wire
Tandem Diabetes Care Launches Tandem Mobi, the World’s Smallest, Durable Automated Insulin Delivery System
February 13, 2024
From
Tandem Diabetes Care, Inc.
Via
Business Wire
Tandem Diabetes Care Announces Upcoming Conference Presentations
February 08, 2024
From
Tandem Diabetes Care, Inc.
Via
Business Wire
7 Tremendous Dividend Stocks With Double-Digit 5-Year Growth Rates
February 07, 2024
When it comes to buying dividend stocks, investors should seek out companies that consistently and repliably grow their payout over time.
Via
InvestorPlace
Abbott Laboratories Surpasses Q4 Sales Expectations, Despite Dip In COVID-19 Testing Demand
January 24, 2024
Abbott Laboratories exceeds expectations with Q4 sales of $10.24B, showcasing resilience despite softer demand for COVID-19 testing. CEO anticipates continued growth in 2024.
Via
Benzinga
Tandem Diabetes Care to Announce Fourth Quarter and Full Year 2023 Financial Results on February 21, 2024
January 22, 2024
From
Tandem Diabetes Care, Inc.
Via
Business Wire
Tandem Diabetes Care’s t:slim X2™ Insulin Pump is the First Automated Insulin Delivery System to Integrate with Abbott’s New FreeStyle Libre® 2 Plus Sensor
January 08, 2024
From
Tandem Diabetes Care, Inc.
Via
Business Wire
Tandem Diabetes Care Announces Full U.S. Launch of Tandem Source, a New Diabetes Management Platform for Customers and Healthcare Providers
December 12, 2023
From
Tandem Diabetes Care, Inc.
Via
Business Wire
Tandem Diabetes Care Launches t:slim X2 Insulin Pump Software with Dexcom G7 CGM Integration in U.S.
December 06, 2023
From
Tandem Diabetes Care, Inc.
Via
Business Wire
Increase Prevalence of Diabetic Patients Driving Market Growth Projected to Reach $55 Billion by 2029
November 17, 2023
EQNX::TICKER_START (OTCPK:CNER),(NASDAQ:PODD),(NASDAQ:TNDM),(NYSE:LLY),(NYSE:ABT) EQNX::TICKER_END
Via
FinancialNewsMedia
NASDAQ:TNDM Investor Notice: Deadline on November 7, 2023 in Lawsuit Against Tandem Diabetes Care, Inc. Coming Up
November 07, 2023
San Diego, CA -- (SBWIRE) -- 11/07/2023 -- The Shareholders Foundation announced that a deadline is coming up on November 7, 2023 in the lawsuit filed for certain investors of Tandem Diabetes Care,...
Via
SBWire
Topics
Lawsuit
Tandem Diabetes Care Announces Upcoming Conference Presentations
November 06, 2023
From
Tandem Diabetes Care, Inc.
Via
Business Wire
TNDM DEADLINE TOMORROW: ROSEN, LEADING INVESTOR COUNSEL, Encourages Tandem Diabetes Care, Inc. Investors to Secure Counsel Before Important November 7 Deadline in Securities Class Action – TNDM
November 06, 2023
From
The Rosen Law Firm PA
Via
GlobeNewswire
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Tandem Diabetes Care, Inc. (TNDM)
November 06, 2023
From
The Law Offices of Frank R. Cruz
Via
Business Wire
TNDM FINAL DEADLINE ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Tandem Diabetes Care, Inc. Investors to Secure Counsel Before Important November 7 Deadline in Securities Class Action - TNDM
November 05, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Economy
Lawsuit
TNDM IMPORTANT DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Tandem Diabetes Care, Inc. Investors to Secure Counsel Before Important November 7 Deadline in Securities Class Action - TNDM
November 04, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Economy
Lawsuit
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.